Placebo-controlled phase III study of Lenograstim in aggressive non-Hodgkin‘s lymphoma: factors influencing chemotherapy administration. - Gisselbrecht,C.; Haioun,C.; Lepage,E.; Bastion,Y.; Tilly,H. (Leukemia and Lymphoma, 1997)